Kais Mnafgui

Kais Mnafgui

Auto-generated profile, based on publicly available information

Kais Mnafgui

Laboratory of Animal Physiology, Faculty of Sciences of Sfax University of Sfax Sfax Tunisia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2014 in Journal of Food Science and Technology
Verified
Journal Article
Closed access
PDF file
KMKais Mnafgui
Kais Mnafgui
ADAmal Derbali
Amal Derbali
SSSami Sayadi
Sami Sayadi
NGNeji Gharsallah
Neji Gharsallah
AEAbdelfattah Elfeki
Abdelfattah Elfeki
NANoureddine Allouche
Noureddine Allouche

1 January 2011 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
Khaled HamdenKhaled Hamden
Khaled Hamden
HKHenda Keskes
Henda Keskes
SBSahla Belhadj
Sahla Belhadj
KMKais Mnafgui
Kais Mnafgui
AFAbdelfattah Feki
Abdelfattah Feki
Noureddine AlloucheNoureddine Allouche
Noureddine Allouche
Diabetes is a serious health problem and a source of risk for numerous severe complications such as obesity and hypertension. Treatment of diabetes and its related diseases can be achieved by inhibiting key digestives enzymes-related to starch digestion secreted by pancreas. The formulation omega-3 with fenugreek terpenenes was administrated to surviving diabetic rats. The inhibitory effects of this oil on rat pancreas α-amylase and maltase and plasma angiotensin-converting enzyme (ACE) were determined. the findings revealed that administration of formulation omega-3 with fenugreek terpenenes (Om3/terp) considerably inhibited key enzymes-related to diabetes such as α-amylase activity by 46 and 52% and maltase activity by 37 and 35% respectively in pancreas and plasma. Moreover, the findings revealed that this supplement helped protect the β-Cells of the rats from death and damage. Interestingly, the formulation Om3/terp modulated key enzyme related to hypertension such as ACE by 37% in plasma and kidney. Moreover administration of fenugreek essential oil to surviving diabetic rats improved starch and glucose oral tolerance additively. Furthermore, the Om3/terp also decreased significantly the glucose, triglyceride (TG) and total-cholesterol (TC) and LDL-cholesterol (LDL-C) rates in the plasma and liver of diabetic rats and increased the HDL-Cholesterol (HDL-Ch) level, which helped maintain the homeostasis of blood lipid. overall, the findings of the current study indicate that this formulation Om3/terp exhibit attractive properties and can, therefore, be considered for future application in the development of anti-diabetic, anti-hypertensive and hypolipidemic foods.

7 April 2015 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
KMKais Mnafgui
Kais Mnafgui
RHRaouf Hajji
Raouf Hajji
FDFatma Derbali
Fatma Derbali
IKInes Khlif
Ines Khlif
FKFtouma Kraiem
Ftouma Kraiem
NGNeji Gharsallah
Neji Gharsallah

21 September 2015 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
KMKais Mnafgui
Kais Mnafgui
RHRaouf Hajji
Raouf Hajji
FDFatma Derbali
Fatma Derbali
AGAnis Gammoudi
Anis Gammoudi
GKGaddour Khabbabi
Gaddour Khabbabi
NGNeji Gharsallah
Neji Gharsallah

25 April 2015 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
ADAmal Derbali
Amal Derbali
KMKais Mnafgui
Kais Mnafgui
MAMarwa Affes
Marwa Affes
FDFatma Derbali
Fatma Derbali
RHRaouf Hajji
Raouf Hajji
AFAbdelfattah El Feki
Abdelfattah El Feki

1 January 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
KMKais Mnafgui
Kais Mnafgui
Khaled HamdenKhaled Hamden
Khaled Hamden
DSDr Hichem Ben Salah
Dr Hichem Ben Salah
MKMouna Kchaou
Mouna Kchaou
MNMbarek Nasri
Mbarek Nasri
AEAbdelfattah Elfeki
Abdelfattah Elfeki
Obesity is a serious health problem that increased risk for many complications, including diabetes and cardiovascular disease. The results showed EZA, which found rich in flavonoids and phenolic compounds, exhibited an inhibitory activity on pancreatic lipasein vitrowith IC50of 91.07 μg/mL.In vivoadministration of this extract to HFD-rats lowered body weight and serum leptin level; and inhibited lipase activity of obese rats by 37% leading to notable decrease of T-Ch, TGs and LDL-c levels accompanied with an increase in HDL-c concentration in serum and liver of EZA treated HFD-rats. Moreover, the findings revealed that EZA helped to protect liver tissue from the appearance of fatty cysts. Interestingly, supplementation of EZA modulated key enzyme related to hypertension such as ACE by 36% in serum of HFD animals and improve some of serum electrolytes such as Na+, K+, Cl−, Ca2+and Mg2+. Moreover, EZA significantly protected the liver-kidney function by reverted back near to normal the values of the liver-kidney dysfunction indices AST&ALT, ALP, CPK and GGT activities, decreased T-Bili, creat, urea and uric acid rates. In conclusion, these results showed a strong antihypelipidemic effect of EZA which can delay the occurrence of dislipidemia and hypertension.